News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Buck Kristen K
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2023 |
4
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 4 on LISATA THERAPEUTICS, INC.|
Txns:
| Granted 18,000 shares
@ $0
Paid exercise price by delivering 2,147 shares
@ $3, valued at
$6.4k
Paid exercise price by delivering 512 shares
@ $3.195, valued at
$1.6k
Granted 9,000 options to buy
@ $3, valued at
$27k
|
|
| 09/02/2022 |
4
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 58,000 shares
@ $0.5, valued at
$29k
Paid exercise price by delivering 25,183 shares
@ $0.5, valued at
$12.6k
Paid exercise price by delivering 44,776 shares
@ $0.5, valued at
$22.4k
|
|
| 01/12/2022 |
4
| Buck Kristen K (EVP, R&D and CMO) has filed a Form 4 on CALADRIUS BIOSCIENCES, INC.|
Txns:
| Granted 64,500 shares
@ $0
Paid exercise price by delivering 7,694 shares
@ $0.917, valued at
$7.1k
Granted 32,500 options to buy
@ $0.917, valued at
$29.8k
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|